Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment

被引:2
|
作者
Wang, Lan [1 ]
Li, Ming [1 ]
Dong, Tiantian [1 ,2 ]
Li, Yuanyuan [1 ]
Yin, Ci [1 ]
Nie, Fang [1 ,2 ]
机构
[1] Lanzhou Univ, Hosp 2, Ultrasound Med Ctr, Cuiyingmen 82, Lanzhou 730030, Peoples R China
[2] Gansu Prov Clin Res Ctr Ultrasonog, Lanzhou 730030, Peoples R China
关键词
ultrasonography; contrast agent; pancreatic neoplasms; hypoxia; tumor microenvironment; GEMCITABINE; CANCER; ULTRASONOGRAPHY; EXPRESSION; PROTEINS; GROWTH; MRI;
D O I
10.3390/diagnostics13203270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A hypoxic microenvironment is associated with an increased risk of metastasis, treatment resistance and poor prognosis of pancreatic ductal adenocarcinoma (PDAC). This study aimed to identify contrast-enhanced ultrasound (CEUS) characteristics that could predict the hypoxic microenvironment of PDAC. A total of 102 patients with surgically resected PDAC who underwent CEUS were included. CEUS qualitative and quantitative characteristics were analyzed. The expression of hypoxia-inducible factor-1 alpha (HIF-1) and glucose transporter-1 (GLUT1) were demonstrated by immunohistochemistry. The associations between CEUS characteristics and the HIF-1 alpha and GLUT1 expression of PDACs were evaluated. We found that HIF-1 alpha-high PDACs and GLUT1-high PDACs had a larger tumor size and were more prone to lymph node metastasis. There was a significant positive linear correlation between the expression of HIF-1 alpha and GLUT1. CEUS qualitative characteristics including completeness of enhancement and peak enhancement degree (PED) were related to the expression of HIF-1 alpha and GLUT1. A logistic regression analysis showed that tumor size, lymph node metastasis, incomplete enhancement and iso-enhancement of PED were independent predictors for HIF-1 alpha-high PDACs and GLUT1-high PDACs. As for quantitative characteristics, HIF-1 alpha-high PDACs and GLUT1-high PDACs showed higher peak enhancement (PE) and wash-in rate (WIR). CEUS can effectively reflect the hypoxia microenvironment of PDAC, which may become a noninvasive imaging biomarker for prognosis prediction and individualized treatment.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic ductal adenocarcinoma
    Jia, Wan-Ying
    Gui, Yang
    Chen, Xue-Qi
    Tan, Li
    Zhang, Jing
    Xiao, Meng-Su
    Chang, Xiao-Yan
    Dai, Meng-Hua
    Guo, Jun-Chao
    Cheng, Yue-Juan
    Wang, Xiang
    Zhang, Jia-Hui
    Zhang, Xiao-Qian
    Lv, Ke
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [2] The role of contrast-enhanced endoscopic ultrasound in pancreatic adenocarcinoma
    Saftoiu, Adrian
    Vilmann, Peter
    Bhutani, Manoop S.
    ENDOSCOPIC ULTRASOUND, 2016, 5 (06) : 368 - 372
  • [3] Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis
    Yang Jie
    Huang Jiayan
    Zhang Yonggang
    Zeng Keyu
    Liao Min
    Jiang Zhenpeng
    Bao Wuyongga
    Lu Qiang
    中华医学杂志英文版, 2023, 136 (17)
  • [4] Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis
    Yang, Jie
    Huang, Jiayan
    Zhang, Yonggang
    Zeng, Keyu
    Liao, Min
    Jiang, Zhenpeng
    Bao, Wuyongga
    Lu, Qiang
    CHINESE MEDICAL JOURNAL, 2023, 136 (17) : 2028 - 2036
  • [5] Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts
    Wegner, Catherine S.
    Hauge, Anette
    Gaustad, Jon-Vidar
    Andersen, Lise Mari K.
    Simonsen, Trude G.
    Galappathi, Kanthi
    Rofstad, Einar K.
    ACTA ONCOLOGICA, 2017, 56 (12) : 1754 - 1762
  • [6] Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis
    Tong, Tong
    Gu, Jionghui
    Xu, Dong
    Song, Ling
    Zhao, Qiyu
    Cheng, Fang
    Yuan, Zhiqiang
    Tian, Shuyuan
    Yang, Xin
    Tian, Jie
    Wang, Kun
    Jiang, Tian'an
    BMC MEDICINE, 2022, 20 (01)
  • [7] Contrast-Enhanced Ultrasound in the Diagnosis of Pancreatic Tumors
    Rickes, Steffen
    Monkemuller, Klaus
    Malfertheiner, Peter
    JOURNAL OF THE PANCREAS, 2006, 7 (06): : 584 - 592
  • [8] Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound
    Lu, Xiu-Yun
    Guo, Xi
    Zhang, Qi
    Qiu, Yi-Jie
    Zuo, Dan
    Chen, Sheng
    Tian, Xiao-Fan
    Zhou, Yu-Hong
    Dong, Yi
    Wang, Wen-Ping
    DIAGNOSTICS, 2022, 12 (11)
  • [9] Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: can we predict survival using perfusion parameters? A pilot study
    Constantin, Alina L.
    Cazacu, Irina M.
    Burtea, Daniela Elena
    Harbiyeli, Irina F. Cherciu
    Bejinariu, Nona
    Popescu, Carmen F.
    Serbanescu, Mircea S.
    Tabacelia, Daniela
    Copaescu, Catalin
    Bhutani, Manoop S.
    Stroescu, Cezar
    Saftoiu, Adrian
    MEDICAL ULTRASONOGRAPHY, 2022, 24 (04) : 393 - 398
  • [10] Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions-A comparison of conventional ultrasound and contrast-enhanced CT
    Fan, Zhihui
    Li, Ying
    Yan, Kun
    Wu, Wei
    Yin, Shanshan
    Yang, Wei
    Xing, Baocai
    Li, Xiaoting
    Zhang, Xiaopeng
    EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (09) : 1385 - 1390